FDA Clears Software for Neck Artery Scans

New imaging software helps clinicians better visualize head and neck arteries, potentially improving diagnostic planning.

Updated on Oct. 28, 2026 in Stroke

Isometric editorial illustration of a translucent geometric carotid artery structure, representing advanced medical vascular imaging software. — The FDA granted 510(k) clearance to Sarasota-based Deep Reasoning AI for its NeuroDR software, which automatically processes arterial scans for clinicians. AI Illustration. Upload story photo >

Live Poll

Do you trust AI-assisted software to accurately assist in medical diagnostic imaging?

The FDA recently granted 510(k) clearance to the NeuroDR software, a new tool designed to assist clinicians in visualizing head and neck arteries on CTA scans. This imaging software, developed by the Sarasota-based firm Deep Reasoning AI, aims to improve the diagnostic workflow for medical teams.

Why it matters

By automating the preparation of complex vascular images, this tool supports documentation and treatment planning for clinicians. Faster and clearer access to 3D arterial renderings may assist in the evaluation of vascular lesions for patients in Sarasota and beyond.

The FDA granted 510(k) clearance for the software following performance studies conducted by 3DR Labs. It remains unknown how the tool impacts long-term diagnostic accuracy or stroke treatment timelines compared to standard imaging practices.

The players

Deep Reasoning AI

A Sarasota-based medical technology company focused on developing artificial intelligence software for medical imaging.

3DR Labs

An imaging services provider that performed the necessary studies to evaluate the software's performance.

Innolitics

A regulatory consultancy that managed the FDA submission and review process for the software.

The details

NeuroDR works by automatically processing CTA scans to isolate arterial structures from surrounding bone, soft tissue, and veins. The system then generates 3D images and volume renderings, which are exported as DICOM files to a facility's picture archiving and communication system, or PACS. This workflow is intended to simplify how radiologists and neurologists visualize arteries when planning interventions or evaluating potential lesions.

October 28, 2026: The FDA granted 510(k) clearance to the NeuroDR software.

Health Landscape

This clearance adds to the growing field of automated software tools designed to optimize Computed Tomography Angiography (CTA) vascular imaging protocols. It follows a broader trend in medical technology of shifting toward AI-assisted processing to expedite clinical decision-making.

If you or a loved one are undergoing vascular imaging, this technology may help streamline the time it takes for your medical team to receive clear, 3D arterial renderings. These diagnostic aids are often part of a wider conversation to have with your neurologist or radiologist regarding your specific treatment plan.

The takeaway

Advanced imaging software aims to help clinicians better visualize head and neck arteries, potentially speeding up lesion evaluation and care planning. When reviewing any brain or vascular imaging results, ask your physician how 3D renderings were used to assist in your diagnosis.